UNCLAIMED
Viatris
Overview
Viatris is a United States-based company operating in the manufacturing sector, specifically within the pharmaceuticals industry. Founded in 2020, the company has grown to employ over 10,001 individuals and reported revenues of approximately $14.12 billion. Viatris aims to create sustainable access to medicine by providing quality pharmaceuticals at scale, catering to diverse populations regardless of geographical or socio-economic circumstances. The company has a significant global presence, having supplied medicines to around one billion patients and distributed over 70 billion doses across more than 165 countries and territories. Viatris focuses on maintaining a resilient and agile supply chain to ensure reliable access to medicines, particularly in times of fluctuating demand. The company has contributed to global health by supplying approximately half of the molecules listed on the EU Critical Medicines List and more than 260 medicines on the WHO Essential Medicines List, including a substantial number of products aimed at low- and middle-income countries. Viatris emphasizes its commitment to managing supply chain challenges through a robust network of suppliers.